Navigation Links
BIO Visitors Bring Viral Preparedness to Atlanta
Date:5/20/2009

North Carolina giveaways show state's growing germ-fighting focus

ATLANTA, May 20 /PRNewswire-USNewswire/ -- Representatives of the North Carolina contingent to this week's Biotechnology Industry Organization (BIO) conference in Atlanta are pressing a point as they press the flesh with thousands of conference participants and residents.

The North Carolina Biotechnology Center is distributing hundreds of containers of hand sanitizers -- two brands, both from North Carolina-based companies. One, Purell, is alcohol-based. The other, Remi-D, is a new FDA-approved product that kills germs without alcohol.

The idea is to help visitors to the conference feel more relaxed about shaking hands while shaking the bushes for business connections on the crowded trade-show floor during this belated flu season. The giveaway, which includes some informal distribution to pedestrians in downtown Atlanta during the week, also high-fives North Carolina's growing reputation as the epicenter of infectious-disease weaponry.

For example, the Old North State is home not only to the companies that make Purell and Remi-D, but also to the North American headquarters of global pharmaceutical titan GlaxoSmithKline.

GSK is one of only two manufacturers in the world that make antiviral flu treatments. The U.S. Centers for Disease Control and Prevention, the World Health Organization and other health groups note that GSK's Relenza is effective against the 2009 strain of A (H1N1) flu virus, often called swine flu.

Relenza is made at the company's plant in Zebulon, about 25 miles east of its RTP headquarters.

Meanwhile, a history-making, 430,000-square-foot flu-vaccine plant is being built by Swiss drug maker Novartis AG in Holly Springs, about 20 miles southwest of Raleigh.

It's the largest biomanufacturing project under construction in the Un
'/>"/>

SOURCE North Carolina Biotechnology Center
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. TechConnect Summit Brings the Global Technology Community to Houston, May 4-6, 2009
2. Council for American Medical Innovation Brings U.S. Leaders in Medicine, Biotechnology and Discovery Together in Chicago for Best and Brightest Forum on Medical Innovation
3. Spectral signs exclusive license agreement to bring sepsis therapeutic to the U.S. market
4. Seminar Will Bring ALS Researchers to Patient Groups
5. Immune Targeting Systems Completes Second Tranche of Series-A Funding Bringing Total Funds Raised to More Than GBP5m
6. Smallest ever quantum dots bring real world applications closer
7. U of T chemistry discovery brings organic solar cells a step closer
8. Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market.
9. Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market
10. Nonprofit Puts the Power to Cure Neurological Disease in the Hands of the Masses: Texting Technology Brings Awareness & Supports Research
11. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)TUSTIN, Calif., Dec. 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that it will release its financial results for the second quarter of fiscal year 2010 on December 10, 2009 at 7
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1
Breaking Biology Technology:Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3
...n Trials to Begin Later This Year - Only N... - Patient-Friendly (No Needles); No Preserv...No Cold Chain Distribution ...ton,Laboratories, Inc. (OTC Bulletin Board: CARN) ...elSite Biotechnologies, Inc. received a shipment,o...
...stering More Than 180,000 Patient Visits Each Year...ervices Company Aspires to Empower ...OLLS, N.J., Feb. 14 MedeFile,International, Inc. ... in,portable electronic medical records management...ollaborative marketing agreement with Hayes Clinic...
...O, China, Feb. 14 /Xinhua-PRNewswire/ -- Shenzhen ...iotech.com ), the world leader,in the use of umbi...ety of,illnesses, announced that Audrey Jones, the...ay to the United Kingdom (UK) with significant,imp...condition known as,cerebellar atrophy. As the late...
Other Biology Technology:Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration 2Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration 3Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration 4Hayes Clinical Labs to Market MedeFile's Proprietary Electronic Medical Record Management Solution to Patients 2Hayes Clinical Labs to Market MedeFile's Proprietary Electronic Medical Record Management Solution to Patients 3Hayes Clinical Labs to Market MedeFile's Proprietary Electronic Medical Record Management Solution to Patients 4Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility 2Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility 3
(Date:12/3/2009)The extinction of plant and animal species can be likened to emptying a museum of its collection, or dumping a cabinet full of potential medicines into the trash, or replacing every local cuisine with
(Date:12/3/2009)Contents of this message: , , Preliminary Press Conference Topics, Last Call! Press Field Trip to California Academy of Sciences museum, Attention PIOs: Sending Press Releases to Fall meeting, N
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 1Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 2Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 3Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 4Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 5Disparities in cancer care reflect hospital resources U M study finds 54956 1Disparities in cancer care reflect hospital resources U M study finds 54956 2Type 1 diabetes linked to immune response to wheat 54951 1Type 1 diabetes linked to immune response to wheat 54951 2
...PHILADELPHIA (March 17, 2008) -- According to rese... like humans in their responses to many sweet tast...erse range of molecules that humans experience as ...ies. For example, aspartame, a sweetener used by h...However, fruit flies respond positively to most sw...
... Stanford, CACurators at one of the worlds most wi...formation Resource, or TAIR, have joined forces wi...d of information dilemma. It is a first-of-its-kin...r entering important genetics and other biological...em will unclog the information highway and signifi...
...Biotechnology discoveries like the method for cre...nduly hindered or taken hostage by private corpora...1st century, an expert from The Australian Nationa... ANU College of Law takes a broad look at the curr...lectual property rights and biological inventions ...
Other Biology News:Like sweets? You're more like a fruit fly than you think... 2Controlling a sea of information 2Biotechnology needs 21st century patent system: Expert 2
LEVAMISOLE SOLUTION from Invitrogen
Rabbit Anti-Human UCP2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Catch and Release® v2.0
Reversible Immunoprecipitation System from Upstate
DTNB from Cayman Chemical
Biology Products: